title: Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.
authors.affiliation: HeteroGeneity, Washington, DC 20011, USA. fhoffman@heterogeneity-LLC.com
authors.forename: Freddie Ann
authors.initials: FA
authors.lastname: Hoffman
authors.forename: James T
authors.initials: JT
authors.lastname: Heimbach
authors.forename: Mary Ellen
authors.initials: ME
authors.lastname: Sanders
authors.forename: Patricia L
authors.initials: PL
authors.lastname: Hibberd
mesh_terms: D035843:Biomedical Research / Q000592:standards; D002986:Clinical Trials as Topic; D003257:Consumer Product Safety; D004345:Drug Industry / Q000592:standards*; D019649:Food Industry / Q000592:standards*; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D019936:Probiotics / Q000592:standards* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration